חוב כולל של החברה: Cardio Diagnostics Holdings Inc. (CDIO)

Cardio Diagnostics is implementing AI solutions and epigenetics for the early detection of cardiac pathologies via blood tests, while outsourcing technical production and cloud services to third-party contractors. The stock price history demonstrates that the separate_debt metric stands at 0.00. A high visionary status in cardiology and growing physician confidence in screening accuracy provide the brand with maximum market recognition.

This indicator tracks the total volume of borrowed funds, allowing investors to perform a real-time assessment of the issuer's financial stability and debt load. By analyzing the total debt volume, one can confirm the high reliability of Cardio Diagnostics (CDIO), whose isolation from global trade conflicts and operations within the protected US healthcare sector minimize default risks when servicing obligations.